|
ZNF597 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.844600E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.651000E-01 |
| Normal-vs-Stage2 |
7.587400E-01 |
| Normal-vs-Stage3 |
3.388100E-02 |
| Normal-vs-Stage4 |
1.796450E-03 |
| Stage1-vs-Stage2 |
3.395600E-01 |
| Stage1-vs-Stage3 |
1.616210E-03 |
| Stage1-vs-Stage4 |
6.34880000000004E-05 |
| Stage2-vs-Stage3 |
1.896790E-01 |
| Stage2-vs-Stage4 |
2.744300E-02 |
| Stage3-vs-Stage4 |
2.138400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.901800E-01 |
| Normal-vs-AfricanAmerican |
1.960420E-02 |
| Normal-vs-Asian |
5.482000E-01 |
| Caucasian-vs-AfricanAmerican |
3.562000E-02 |
| Caucasian-vs-Asian |
7.546600E-01 |
| AfricanAmerican-vs-Asian |
5.941800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.232580E-01 |
| Normal-vs-Female |
6.950800E-01 |
| Male-vs-Female |
3.797600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.511010E-01 |
| Normal-vs-Age(41-60Yrs) |
5.637200E-01 |
| Normal-vs-Age(61-80Yrs) |
4.445600E-01 |
| Normal-vs-Age(81-100Yrs) |
5.805600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.828800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.241400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.694200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.377200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.616800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.228400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.608810E-01 |
| Normal-vs-Grade 2 |
2.311000E-01 |
| Normal-vs-Grade 3 |
1.045020E-01 |
| Normal-vs-Grade 4 |
3.65439999999717E-05 |
| Grade 1-vs-Grade 2 |
2.635800E-01 |
| Grade 1-vs-Grade 3 |
1.750360E-02 |
| Grade 1-vs-Grade 4 |
2.007000E-04 |
| Grade 2-vs-Grade 3 |
1.540490E-03 |
| Grade 2-vs-Grade 4 |
2.43400000154992E-08 |
| Grade 3-vs-Grade 4 |
2.060900E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.299680E-02 |
| Normal-vs-ccB subtype |
2.428000E-02 |
| ccA subtype-vs-ccB subtype |
1.7766000004471E-07 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.938400E-01 |
| Normal-vs-N1 |
3.504000E-02 |
| N0-vs-N1 |
1.674190E-01 |
|
|
